-+ 0.00%
-+ 0.00%
-+ 0.00%

MAPLIGHT THERAPEUTICS RECEIVES FAST TRACK DESIGNATION FOR ML-007C-MA FOR ALZHEIMER’S DISEASE PSYCHOSIS

Reuters·01/05/2026 12:00:03

Please log in to view news